Startups
Disruptive Innovation to Combat Antimicrobial Resistance
Edit

Disruptive Innovation to Combat Antimicrobial Resistance

http://www.procartabio.com/
Last activity: 05.03.2019
Active
Categories: Development
Procarta Biosystems Ltd aims to revolutionise the treatment of serious and life-threatening infection through the development of innovative new oligonucleotide-based antimicrobials.
Email
Mentions
2

Overview

Employees
11-50
Total raised
$2.87M
Founded date
2008

Funding Rounds 2

DateSeriesAmountInvestors
Sign up to seeSign up to seeSign up to seeSign up to see
Nov 12, 2010Funding round$1.18M

Mentions in press and media 2

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Nov 12, 2010Procarta Biosystems Raises £730,000 in Equity FinancingProcarta Biosystems Ltd., a Norwich, UK-based developer of an innovative class of DNA-based antibiotics designed to tackle drug-resistant infections, has raised £730,000 in equity financing. The round, which was led by Morningside Venture I...

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about Disruptive Innovation to Combat Antimicrobial Resistance

When was Disruptive Innovation to Combat Antimicrobial Resistance founded?

Disruptive Innovation to Combat Antimicrobial Resistance was founded in 2008.

How much funding has Disruptive Innovation to Combat Antimicrobial Resistance raised?

Disruptive Innovation to Combat Antimicrobial Resistance has raised $2.87M in total across 2 funding rounds.

What funding rounds has Disruptive Innovation to Combat Antimicrobial Resistance raised?

Parsers VC lists 2 funding rounds of Disruptive Innovation to Combat Antimicrobial Resistance, among them a funding round of $1.18M on Nov 12, 2010.

What has the press written about Disruptive Innovation to Combat Antimicrobial Resistance?

Parsers VC has collected 2 articles mentioning Disruptive Innovation to Combat Antimicrobial Resistance, among them “Procarta Biosystems Raises £730,000 in Equity Financing” (Nov 12, 2010).

Is Disruptive Innovation to Combat Antimicrobial Resistance still active?

Yes, Disruptive Innovation to Combat Antimicrobial Resistance is active; its latest activity on Parsers VC dates from Mar 5, 2019.